ZNF711

Across TCGA pan-cancer cohorts, ZNF711 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated ZNF711 data layer compared with 28 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ZNF711 Mutation is associated with better overall survival. In most high-consensus cancer types, elevated ZNF711 expression acts as an unfavorable survival marker, although some lineages such as UCEC and BLCA show a favorable association.

UCEC, BLCA, and LUAD are the cancer types where ZNF711 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	II,III,IV	1.000	0.499	.007	34	view →
BLCA	DFS	Median	All	1.000	0.325	.015	10	view →
LUAD	DFS	Median	IV	0.047	0.565	<.001	6	view →
BRCA	DFS	Median	All	0.647	0.903	.008	4	view →
ACC	DFS	Median	All	0.195	0.748	.003	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

ZNF711–UCEC (OS)

Open the UCEC breakdown →